Maravai LifeSciences Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Maravai LifeSciences Holdings, Inc. (MRVI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.01 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 1.01M shares, a 71.48% increase from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 589.00K shares, a 31.35% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 858.00K shares, a 288.24% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 221.00K shares, a 60.11% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|
| 2025-12-31 | 1.01M shares 10-K · filed 2026-02-26 |
| 2024-12-31 | 589.00K shares 10-K · filed 2025-03-18 |
| 2023-12-31 | 858.00K shares 10-K · filed 2024-02-29 |
| 2022-12-31 | 221.00K shares 10-K · filed 2023-02-28 |
| 2021-12-31 | 554.00K shares 10-K · filed 2022-03-01 |